Immuno 2026 Day 5 Highlights: Engineered Cell Therapies, Solid Tumors, and the Future of Pediatric Immunotherapy
Fatima Cardoso Named Candidate for UICC Board of Directors 2026–2028
Merck Enters $2.13 Billion License Agreement for SciBrunch’s Investigational Oral KRAS G12D (ON) Inhibitor SPR2015
CancerWorld Explores Tanzania’s Transformation in Childhood Cancer Care
Applications are Open for the Improving Cancer Outcomes and Leadership Course - ESO
ITM and Lumara Bio Present Real-World Re-treatment Data and Dosimetry Results for ¹⁷⁷Lu-Edotreotide (ITM-11) in GEP-NETs at ASTRO 2026
10 Must-Read Posts In GI Oncology This Week
Tiffany Patrick: How The Max Foundation Transforms Access Into Patient Impact?
